Cullgen

Cullgen is a biopharmaceutical company that has developed protein degradation technology that utilizes the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.

Industries

Stage

Series B

Employees

51-200

Links

Org chart

Ying Luo
Chairman & President
Collapse
Yue Xiong
Chief Scientific Officer
Mark Deeg
EVP, Clinical Development
Michael Plewe
SVP, Medicinal Chemistry
Jialiang Wang
VP, Translational Medicine
Hengxu Wei
VP, CMC & Regulatory Affairs
Leslie Robinson
VP, Intellectual Property & Licensing